Professional Documents
Culture Documents
Artículo de revisión
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Carlos R. Camara. BRAIN. Journal of Neurology. 2018
z
La barrera intestinal
z
Desmielinización del SNC y Ruptura de
barrera intestinal en trastornos
gastrointestinales
EII
Crohn
CUCI
Enfermerdad celiaca
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Carlos R. Camara. BRAIN. Journal of Neurology. 2018
z
Barrera intestinal:
Homeostasis, Microbioma,
Neuroinflamación
Anerostipes
Faecalibacterium
Pseudomonas Pacientes con Esclerosis Múltiple remitente y
Mycoplasma con recaídas
Haemophilis
Blautia Fenotipos pro y anti-inflamatorios
Dorea
Entre menos flora, menos severo
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Carlos R. Camara. BRAIN. Journal of Neurology. 2018
z
Barrera intestinal:
Homeostasis, Microbioma,
Neuroinflamación
z
Barrera intestinal en Esclerosis Múltiple
Malabsorción
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Carlos R. Camara. BRAIN. Journal of Neurology. 2018
z
Terapias acorde a barrera intestinal
z
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Carlos R. Camara. BRAIN. Journal of Neurology. 2018
z
Interferón
IFN a
IFN b
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Carlos R. Camara. BRAIN. Journal of Neurology. 2018
z
Acetato de Glatiramer
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Carlos R. Camara. BRAIN. Journal of Neurology. 2018
z
Natalizumab
Nuevo: Vedolizumab
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Carlos R. Camara. BRAIN. Journal of Neurology. 2018
z
Fingolimod
Regulación leucocitaria
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Carlos R. Camara. BRAIN. Journal of Neurology. 2018
z
Dimetilfumarato
Apoptosis de células T
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Carlos R. Camara. BRAIN. Journal of Neurology. 2018
z
Alemtuzumab
Depleta linfocitos
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Carlos R. Camara. BRAIN. Journal of Neurology. 2018
z
Teriflunomide
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Carlos R. Camara. BRAIN. Journal of Neurology. 2018
z
Minociclina
Anti-inflamatorio
Inmunomodulador
Anti-apoptótico
Altera microflora
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Carlos R. Camara. BRAIN. Journal of Neurology. 2018
z
Tratamiento de la barrera intestinal
enferma
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Carlos R. Camara. BRAIN. Journal of Neurology. 2018
z
Conclusión
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Carlos R. Camara. BRAIN. Journal of Neurology. 2018